Literature DB >> 15521920

T-cell post-transplantation lymphoproliferative disorders after cardiac transplantation: a single institutional experience.

H Y Draoua1, Lawrence Tsao, Donna M Mancini, Linda J Addonizio, Govind Bhagat, Bachir Alobeid.   

Abstract

Post-transplantation lymphoproliferative disorders (PTLDs) are a well-recognized and potentially life-threatening complication of solid organ transplantation. While the vast majority of PTLDs are B-cell lymphoproliferations, T-cell PTLDs are rarely seen. Among 898 patients receiving cardiac transplants between 1990 and 2003, 34 patients (3.8%) developed PTLDs with two (0.2%) T-cell PTLDs, 31 (3.5%) B-cell PTLDs and one (0.1%) natural killer cell PTLD. An additional three cases of T-cell PTLD were identified among all cardiac transplant patients followed at our institution. These T-cell PTLDs comprised a heterogeneous group of Epstein-Barr virus negative lymphoproliferations that developed late after transplantation and followed an aggressive course.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15521920     DOI: 10.1111/j.1365-2141.2004.05212.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  11 in total

Review 1.  EBV-associated lymphomas in adults.

Authors:  Mark Roschewski; Wyndham H Wilson
Journal:  Best Pract Res Clin Haematol       Date:  2012-02-05       Impact factor: 3.020

Review 2.  Management of Non-Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder.

Authors:  Ajay Major; Manali Kamdar
Journal:  Curr Treat Options Oncol       Date:  2018-05-24

Review 3.  Lymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processes.

Authors:  Kieron Dunleavy; Mark Roschewski; Wyndham H Wilson
Journal:  Curr Hematol Malig Rep       Date:  2012-09       Impact factor: 3.952

4.  Pediatric T-cell post-transplant lymphoproliferative disorder after solid organ transplantation.

Authors:  Fan Yang; Ying Li; Raul Braylan; Stephen P Hunger; Li-Jun Yang
Journal:  Pediatr Blood Cancer       Date:  2008-02       Impact factor: 3.167

Review 5.  Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder.

Authors:  Margaret L Gulley; Weihua Tang
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

Review 6.  Pediatric post-transplant lymphoproliferative disorder after cardiac transplantation.

Authors:  Hideaki Ohta; Norihide Fukushima; Keiichi Ozono
Journal:  Int J Hematol       Date:  2009-08-12       Impact factor: 2.490

7.  Post cardiac transplantation T-cell lymphoproliferative disorder presenting as a solitary lung nodule.

Authors:  Barina Aqil; Bhuvaneswari Krishnan; Choladda V Curry; M Tarek Elghetany; Reka Szigeti
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

8.  Small-Sized Clone of T Cells in Multiple Myeloma Patient after Auto-SCT: T-LGL Leukemia Type or Clonal T-Cell Aberration?

Authors:  Giuseppe Mele; Marilena Greco; Maria Rosaria Coppi; Giacomo Loseto; Angela Melpignano; Salvatore Mauro; Gianni Quarta
Journal:  Case Rep Hematol       Date:  2013-04-21

9.  Genetic landscape of T- and NK-cell post-transplant lymphoproliferative disorders.

Authors:  Elizabeth Margolskee; Vaidehi Jobanputra; Preti Jain; Jinli Chen; Karthik Ganapathi; Odelia Nahum; Brynn Levy; Julie Morscio; Vundavalli Murty; Thomas Tousseyn; Bachir Alobeid; Mahesh Mansukhani; Govind Bhagat
Journal:  Oncotarget       Date:  2016-06-21

10.  Durable Response to Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, and Prednisone (BV-CHP) in a Patient with CD30-Positive PTCL Arising as a Post-Transplant Lymphoproliferative Disorder (PTLD).

Authors:  Jennifer Hong; William T Johnson; Saritha Kartan; Anitha S Gonsalves; Jonathan M Fenkel; Jerald Z Gong; Pierluigi Porcu
Journal:  Curr Oncol       Date:  2021-12-02       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.